Evidence map›Paper›PMID 40911573›Full record

ArticlePLOS global public health2025

Mortality rate and predictors among stroke patients in the public hospitals in Harari region, Eastern Ethiopia.

Alemayehu Tesfaye, Lemma Demissie Regassa, Birhanu Shegene, Nano Belema Areda, Assefa Tola

Abstract read
In one paragraph

Article in PLOS global public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Alemayehu TesfayeSchool of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID https://orcid.org/0009-0001-5188-1720
Lemma Demissie RegassaSchool of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.
Birhanu ShegeneSchool of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID https://orcid.org/0009-0001-2223-1948
Nano Belema AredaDepartment of Midwifery, College of Medicine and Health Science, Dire Dawa University, Dire Dawa, Ethiopia.
Assefa TolaSchool of Public Health, College of Health and Medical Sciences, Haramaya University, Harar, Ethiopia.ORCID https://orcid.org/0000-0002-2155-6097

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Stroke is a major cause of death and disability worldwide, yet there is limited information on the mortality rate and its predictors in Eastern Ethiopia. This lack of evidence is particularly significant, as hospitals in the Harari region provide the majority of healthcare services for stroke and chronic diseases. Therefore, our objective is to assess the mortality rate and predictors among stroke patients in the public hospitals in Harari. An institutional-based retrospective follow-up study was conducted among 452 randomly selected stroke patients at public hospitals in the Harari region from July 1, 2019, to June 30, 2024. The incidence of unfavorable treatment outcomes was calculated at 95% CI, and predictors of mortality were determined using Cox regression analyses. Of the 452 patients included, 292 (64.6%) improved, 21 (4.7%) were discharged with complications, 63 (13.9%) died, and 76 (16.8%) were discharged against medical advice. The 60-month follow-up revealed a mortality rate of 7.6 (95% CI: 5.9-9.7) per 1,000 person-months. The mortality risk was higher among stroke patients with hypertension (AHR: 2.0, 95% CI: 1.1-3.9), heart failure (AHR: 2.2, 95% CI: 1.1, 4.9), those with complications (AHR: 4.9, 95% CI: 1.5, 16.3), hospital-acquired infections (AHR: 3.1, 95% CI: 1.5-6.7), aspiration pneumonia (AHR: 1.9, 95% CI: 1.1-3.4), poor Glasgow Coma Scale (GCS) scores (AHR: 6.9, 95% CI: 2.4-19.9), and moderate impairment in GCS (AHR: 4.7, 95% CI: 1.6-13.3). Conversely, the use of antiplatelet drugs was associated with a reduced mortality risk in stroke patients (AHR: 0.5, 95% CI: 0.3-0.9). The mortality rate of stroke in this study was comparable to that of other studies in Ethiopia. Factors such as hypertension, heart failure, lower GCS, complications, aspiration pneumonia, and hospital-acquired infections increased mortality risks, while antiplatelet drugs reduced them. Therefore, strategies for early screening and follow-up of at-risk patients are essential.

Identifiers

PMID40911573
PMCPMC12412954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.